MRFF Clinical Trials Activity Initiative 2025 – International Clinical Trial Collaborations
The MRFF Clinical Trials Activity Initiative 2025 funds Australian sites to join investigator-initiated international clinical trials, building capacity for world-class trial coordination and generating evidence on novel treatments in real-world care settings.
Eligibility Criteria:
-
Host Organisation: Must be an approved MRFF Eligible Organisation (see NHMRC’s List of MRFF Eligible Organisations).
-
Lead Investigator: Independent clinical trial investigators at Australian academic or research institutions.
-
Trial Status: The international trial must not have commenced recruitment at Australian site(s).
-
Compliance: Applications must meet all requirements in the MRFF Clinical Trials Activity Initiative 2025 grant guidelines.
Funding Details:
-
Total Budget: AUD 13 million
-
Award Size: Up to AUD 3 million per project (direct costs plus 10% indirect costs)
-
Duration: Up to 7 years from grant execution
-
Use of Funds: Establishment and coordination of Australian trial site(s); participant recruitment; data collection in usual-care settings.
Important Deadlines:
-
Round 1 Minimum Data Submission: 2 July 2025, 5 pm (ACT)
-
Round 1 Questions Close: 23 July 2025, 1 pm (ACT)
-
Round 2 Minimum Data Submission: 10 December 2025, 5 pm (ACT)
-
Round 2 Questions Close: 28 January 2026, 1 pm (ACT)
-
Full Application Submission (both rounds): 4 February 2026, 5 pm (ACT)
How to Apply & Further Information:
-
Online Submission: NHMRC Sapphire system
-
Email: [email protected]
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023